Epicrispr Biotechnologies
1 known investors
Epicrispr Biotechnologies develops therapies that dynamically control gene expression using the epigenome to treat complex diseases. Its Gene Expression Modulation System (GEMS) platform combines epigenomic modulators to build therapies customized for specific disease indications.
BiotechDeep TechHealthtech
Investors · 1
Frequently asked questions
- What does Epicrispr Biotechnologies do?
- Epicrispr Biotechnologies develops therapies that dynamically control gene expression using the epigenome to treat complex diseases. Its Gene Expression Modulation System (GEMS) platform combines epigenomic modulators to build therapies customized for specific disease indications.
- Who are Epicrispr Biotechnologies's investors?
- Epicrispr Biotechnologies's investors include Ally Bridge Group.